Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anne Chiron"'
Autor:
Isabelle Roque, Corinne Bodenant, Pierre Michel, Thierry Frebourg, Anne Chiron, Bernard Paillot, Valérie Robert, Karine Magois, Sok H Seng, Florence Lepessot
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 54:379-385
The aim of this study was to evaluate biologic factors on survival and clinical response after definitive concomitant chemoradiotherapy (CRT) in patients with esophageal squamous cell carcinoma (ESCC).TP53 protein hyperexpression (immunochemistry [IH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25bb507b07c552f8e766a2dee2e9b78
https://doi.org/10.1016/s0360-3016(02)02911-5
https://doi.org/10.1016/s0360-3016(02)02911-5
Autor:
Anne Chiron, Pierre Michel, Peillon C, Philippe Ducrotté, Philippe Denis, Isabelle Le Blanc-Louvry
Publikováno v:
Journal of the American College of Surgeons. 190:408-417
Background: The aims of this study were to compare Roux-en-Y limb motor patterns after total or distal gastrectomy, and to identify possible motor differences between symptomatic and asymptomatic patients. The usefulness of preoperative recording was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49deb1c4e16427d590a60936c30fd0bc
https://doi.org/10.1016/s1072-7515(99)00293-8
https://doi.org/10.1016/s1072-7515(99)00293-8
Autor:
Cosette Martin, Françoise Charbonnier, Jean Michel Flaman, Valérie Robert, Pierre Michel, Thierry Frebourg, Bernard Paillot, Anne Chiron
Publikováno v:
Carcinogenesis. 21:563-565
Somatic mutations of the tumor suppressor gene p53 have been frequently detected in esophagal cancers, but their biological significance remains to be established. The tumor suppressor activity of p53 results in part from its ability to transactivate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df728caf6b07e8a5b34aa8afa941281
https://doi.org/10.1093/carcin/21.4.563
https://doi.org/10.1093/carcin/21.4.563
Autor:
Philippe Ducrotté, Véronique Merle, Anne Chiron, Raymond Colin, Bernard Paillot, Pierre Czernichow, Pierre Michel, Hecketsweiler P
Publikováno v:
Gastroenterology. 117(4)
Background & Aims: Two separate decisions must be made for the management of patients with resected stage II/III colon cancer: whether to begin adjuvant chemotherapy and whether patients should be included in a follow-up protocol consisting of regula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b5b519f2d818ec2e5af18d4d0c79dd
https://pubmed.ncbi.nlm.nih.gov/10500083
https://pubmed.ncbi.nlm.nih.gov/10500083